Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation
The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Research over the years has shown that causes of Alzheimer's disease are not well understood, but over the past years, the involvement of epigenetic mechanisms in the developing memory formation either under pathological or physiological conditions has become clear. The term epigenetics represents the heredity of changes in phenotype that are independent of altered DNA sequences. Different studies validated that cytosine methylation of genomic DNA decreases with age in different tissues of mammals, and therefore, the role of epigenetic factors in developing neurological disorders in aging has been under focus. In this review, we summarized and reviewed the involvement of different epigenetic mechanisms especially the DNA methylation in Alzheimer's disease (AD), late-onset Alzheimer's disease (LOAD), familial Alzheimer's disease (FAD), and autosomal dominant Alzheimer's disease (ADAD). Down to the minutest of details, we tried to discuss the methylation patterns like mitochondrial DNA methylation and ribosomal DNA (rDNA) methylation. Additionally, we mentioned some therapeutic approaches related to epigenetics, which could provide a potential cure for AD. Moreover, we reviewed some recent studies that validate DNA methylation as a potential biomarker and its role in AD. We hope that this review will provide new insights into the understanding of AD pathogenesis from the epigenetic perspective especially from the perspective of DNA methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal DNA methylation patterns have been reported in several genes associated with AD [227,228,229].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [227]
In the citing paper
“differences in overall methylation have been observed in AD-affected brain regions”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [227]
Citations
Cites
1 retracted
Kuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 117
RetractedCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“Studies on mice have shown that during gametogenesis and early development, this event occurs frequently in order to remethylate the demethylated repetitive sequences during those stages of embryogenesis [18].”
BackgroundConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“In neurons, DNA hydroxymethylation can occur in result of oxidative stress or the action ten-eleven-translocation-1(TET1), which is a specific oxidative enzyme [21, 22].”
BackgroundDelivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Genome-wide methylation profiles reveal quantitative views of human aging rates
Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.016 · Cited by 4,270
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · cited 1×
“A decreased and silenced transcription of genes is achieved when MBDP along with other epigenetic components forms inactive and compact heterochromatin [20].”
Background
Research works printed but not linked: 1
- van Emburgh BO, Robertson KD (2008) DNA methyltransferases and methyl-CpG binding proteins as multifunctional regulators of chromatin structure and development in mammalian cells. In: Tost J (ed) Epigenetics. Caister Academic Press, Norfolk, pp. 22–61
Cited by
Clinical epigenetics: seizing opportunities for translation
Berdasco, M., & Esteller, M. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0074-2 · Cited by 498
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 329
Ribosome biogenesis in disease: new players and therapeutic targets
Jiao, L., Liu, Y., Yu, X.-Y., Pan, X., Zhang, Y., Tu, J., Song, Y.-H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01285-4 · Cited by 313
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“It has been demonstrated that in AD brains changes in DNA methylation affect to a few common gene loci which play an essential role in the formation of Aβ plaques (Lord and Cruchaga, 2014; Watson et al., 2016; Qazi et al., 2018; Armstrong et al., 2019; Esposito and Sherr, 2019; Prasad and Jho, 2019).”
Background
Metadata
- Authors
- Qazi, T. J., Quan, Z., Mir, A., & Qing, H.
- Affiliations
- Beijing Institute of Technology (CN)
- International Islamic University, Islamabad (PK)
- Corresponding author
- Qing, Hong
- Venue
- Molecular Neurobiology
- Published
- 2017-01-14
- Volume
- 55
- Issue
- 2
- Pages
- 1026-1044
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2572342044
- Cited by
- 153
- References
- 195
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 22 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 8 · 2018: 12 · 2017: 9
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81671268)
- Ministry of Science and Technology of the People’s Republic of China (No. 2013YQ03059514)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, DNA methylation, epigenetics, late-onset Alzheimer's disease, familial Alzheimer's disease, autosomal dominant Alzheimer's disease, mitochondrial DNA methylation, aging, memory formation, epigenetic biomarkers, epigenetic therapy, Alzheimer's disease pathogenesis
- MeSH terms
- Alzheimer Disease, DNA, Mitochondrial, Humans, Mitochondria, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation. https://app.cochat.ai/papers/10.1007/s12035-016-0357-6
- The paper
- Qazi, T. J., Quan, Z., Mir, A., & Qing, H. (2018). Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation. Molecular Neurobiology. https://doi.org/10.1007/s12035-016-0357-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.